Cancer is currently the most dangerous disease. Eric Lefkofsky co-founded a company called Tempus, mainly focused on using genomic sequencing to help customize cancer treatments. Recently, the Chicago based company, Tempus, announced that it raised $ 70 million from New Enterprise Associates and Revolution Growth in its series C funding. This financing will sum up the total amount raised since Tempus was established in 2015 to $ 130 million and more information click here.
Eric Lefkofsky who serves as the CEO and his business partner, Brad Keywell take part significantly in every fundraising round for Tempus. Last year, Eric told Crain’s Chicago that he is willing to invest up to $ 100 million in the business. Investors New Enterprise Associates and Revolution Growth have also funded companies like stock trading app Robinhood and salad restaurant Sweetgreen respectively among others and Eric on Facebook.
After many years in the tech industry, Eric Lefkofsky ventured into the healthcare when a loved one was diagnosed with breast cancer. During treatment, Eric realized there is short of technology on how data collection was conducted. Tempus was then established, which has created platforms of technology that compile genomic and clinical data from cancer patients making it easier for doctors to personalize the treatment.
Datasets have been small and disorganized but with Tempus massive amount of molecular and clinical data are amassed benefiting the patient. Last year Tempus announced partnerships withDuke University School of medicine, the Mayo Clinic, Cleveland Clinic and many others. Tempus looks forward to building the world’s most extensive library of clinical and molecular data to customize and improve cancer treatment and Eric’s lacrosse camp.
Eric Lefkofsky was born in Southfield, Michigan but most of his adult life was in Chicago. He graduated with honors from the University of Michigan. Later, he attained his Juris Doctor from the University of Michigan, Law School. He also serves as the chairman of Groupon, and co-founder of Uptake Technologies.
Together with Brad Keywell, they have established several companies like VC fund Lightbank. Eric has committed staff members at Tempus who work hard to provide care to cancer patients. Eric and his wife established Lefkofsky Foundation to support organizations globally. Caring for patients and loved ones is the motive of Tempus and http://www.chicagobusiness.com/article/20161001/ISSUE01/310019995/can-eric-lefkofsky-save-your-life.